Oncorus to Present at Upcoming Investor Conferences

On November 23, 2021 Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, reported that President and Chief Executive Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will participate in two upcoming virtual investor conferences (Press release, Oncorus, NOV 23, 2021, View Source [SID1234595978]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

33rd Annual Piper Sandler Virtual Healthcare Conference: A corporate presentation will be available on-demand starting Monday, November 22nd at 10:00 a.m. ET.
Evercore ISI 4th Annual HealthCONx Conference: Fireside chat on Wednesday, December 1st, 2021 at 4:45 p.m. ET.
A webcast of each conference presentation will be available under the Investors & Media section of Oncorus’ website at View Source A replay of the presentations will be archived on Oncorus’ site for 30 days following the event.